Synthesis of Hindered Hydrazones and Their Reaction with Thionyl Chloride 227
Found: C, 59.38; H, 4.86; N, 7.20%. IR (neat): νNH
Spirochroman(2,1ꢁ)cyclohexane-4-one (2,4,6-Tri-
chlorophenyl)hydrazone (14f). The compound
(purified by column chromatography on sil-
ica gel, Merck 60, particle size 0.06–0.20 mm,
ether/petroleum ether 40–60◦C 1:10) was isolated
(2.80 g, 76%) as brownish oil. Anal calcd for
C20H19Cl3N2O (409.74): C, 58.62; H, 4.67; N, 6.83%.
1
3342; νC 1598 cm−1. H NMR (CDCl3): δ 0.82 (t,
N
J = 8.00 Hz, 3H, CH3CH2), 0.98 (s, 3H, CH3), 1.41
(q, J = 8.00 Hz, 2H, CH2CH3), 2.55 (d, J = 18.00 Hz,
1H, 4-CH Hb), 2.59 (d, J = 18.00 Hz, 1H, 4-CHa H ),
a
b
3.40 (s, 2H, CH2), 7.10–7.43 (m, 5H, ArH), 8.13
(d, J = 8.00 Hz, 1H, ArH), 10.08 ppm (s, H, NH,
exchangeable with D2O). MS (EI): m/z (%) 386 (M, 3
Cl37, 25), 384 (M, 2 Cl37 Cl35, 80), 382 (M, Cl37 2 Cl35,
90), 380 (M, 3 Cl35, 98), 371 (4), 369 (12), 367 (28),
365 (40), 357 (5), 355 (23), 353 (34), 351 (49), 346
(98), 315 (44), 274 (26), 208 (40), 195 (97), 187 (25),
170 (97), 167 (95), 159 (23), 143 (96), 131 (40), 128
(100), 110 (86), 89 (47).
Found: C, 58.35; H, 4.60; N, 6.79%. IR (neat): νNH
1
3315; νC 1600 cm−1. H NMR (CDCl3): δ 1.32–1.77
N
(m, 10H, (CH2)5), 2.68 (s, 2H, CH2), 6.91–7.02 (m,
3H, ArH), 7.19–7.35 (m, 2H, ArH), 8.10 (d, J = 8.00
Hz, 1H, ArH), 10.03 ppm (s, 1H, NH, exchangeable
with D2O). MS (EI): m/z (%) 414 (M, 3 Cl37, 3), 412
(M, 2 Cl37 Cl35, 14), 410 (M, Cl37 2 Cl35, 30), 408 (M, 3
Cl35, 38), 216 (62), 190 (36), 185 (38), 179 (16), 173
(82), 159 (20), 145 (15), 131 (21), 121 (100), 91 (35).
2,2-Dimethylchroman-4-one (4-Nitrophenyl)hyd-
razone (14c). Dark yellow crystals (2.69 g, 85%), mp
192–194◦C (literature [11] 193–194◦C). Anal calcd for
C17H17N3O3 (311.33): C, 65.57; H, 5.50; N, 13.49%.
Found: C, 65.35; H, 5.40; N, 13.28%. IR (KBr): νNH
3355; νC N 1616 cm−1. 1H NMR (CDCl3): δ 1.45 (s, 6H,
2 CH3), 2.72 (s, 2H, CH2), 6.98–7.43 (m, 6H, ArH),
8.09 (d, J = 8.01 Hz, 2H, ArH) 10.12 ppm (s, 1H,
NH, exchangeable with D2O). MS (EI): m/z (%) 311
(M, 80), 296 (100), 281 (60), 235 (40), 159 (28), 121
(52), 91 (35).
Preparation of Chlorothiadiazolines 15a–c
Hydrazone 14 (0.01 mol) was added portionwise to
thionyl chloride (20 ml) with stirring. The mixture
was stirred at room temperature for 10 h. The excess
of thionyl chloride was removed under reduced pres-
sure and recrystallization from ethyl acetate afforded
the corrresponding chlorothiadiazolines 15a–c.
(3aRS, 4RS) 3a-Chloro-4-ethyl-4-methyl-2-(4-ni-
trophenyl)-3a,4,5,9b-tetrahydronaphtho[1,2-d]-ꢀ1, 9b
-
[1,2,3]thiadiazoline (15a). Yellow crystalline pow-
der (3.50 g, 91%), mp 272–274◦C. Anal calcd for
C19H18ClN3O2S (387.86): C, 58.83; H, 4.67; N, 10.83;
2,2-Dimethylchroman-4-one (2,4,6-Trichlorophe-
nyl)hydrazone (14d). Yellowish-green crystals (2.90
g, 83%), mp 138–140◦C. Anal calcd for C17H15Cl3N2O
(369.68): C, 55.22; H, 4.09; N, 7.57%. Found: C, 55.01;
S, 8.26%. Found: C, 58.74; H, 4.55; N, 10.62; S,
1
8.16%. IR (KBr): νC 1594 cm−1. H NMR (DMSO-
N
H, 3.98; N, 7.52%. IR (KBr): νNH 3355; νC 1616
N
d6): δ 0.98 (t, J = 8.00 Hz, 3H, CH3CH2), 1.00 (t,
J = 8.00 Hz, 3H, CH3CH2), 1.02 (s, 3H, CH3), 1.31
(s, 3H, CH3), 1.62–1.78 (m, 2H, CH2CH3), 1.81–
2.00 (m, 2H, CH2CH3), 2.97 (d, J = 18.00 Hz, 1H,
CH Hb), 3.00 (d, J = 18.00 Hz, 1H, CH Hb), 3.22 (d,
cm−1. H NMR (CDCl3): δ 1.46 (s, 6H, 2 CH3), 2.72
1
(s, 2H, CH2), 6.84–6.96 (m, 3H, ArH), 7.19–7.34 (m,
2H, ArH), 7.98 (d, J = 8.01 Hz, 1H, ArH) 10.01 ppm
(s, 1H, NH, exchangeable with D2O). MS (EI): m/z
(%) 374 (M, 3 Cl37, 4), 372 (M, 2 Cl37 Cl35, 31), 370
(M, Cl37 2 Cl35, 98), 368 (M, 3 Cl35, 100), 357 (7),
355 (28), 353 (28), 333 (25), 194 (10), 174 (11), 159
(12).
a
a
J = 18.00 Hz, 1H, 5-CHa H ), 3.28 (d, J = 18.00 Hz,
b
1H, 5-CHa H ), 7.12–7.20 (m, 3H, ArH), 7.25–7.31
b
(m, 4H, ArH), 7.42–7.50 (m, 3H, ArH), 7.55–7.61 (m,
4H, ArH), 8.00 (d, J = 8.00 Hz, 1H, ArH), 8.21 (d,
J = 8.00 Hz, 1H, ArH). MS (EI): m/z (%) 389 (M,
Cl37, 0.22), 387 (M, Cl35, 0.62), 352 (M+ − Cl, 100),
337 (50), 330 (35), 323 (60), 306 (10), 294 (4), 170
(5), 156 (15), 130 (20), 91 (40).
Spirochroman(2,1ꢁ)cyclohexane-4-one (4-Nitro-
phenyl)hydrazone (14e). Yellowish-brown crystals
(2.80 g, 80%), mp 245–248◦C. Anal calcd for
C20H21N3O3 (351.39): C, 68.35; H, 6.02; N, 11.96%.
Found: C, 68.10; H, 5.92; N, 11.75%. IR (KBr): νNH
(3aRS) 3a-Chloro-4,4-dimethyl-2-(4-nitrophenyl)-
1
3322; νC 1598 cm−1. H NMR (CDCl3): δ 1.33–1.77
chromane[4,3-d]-ꢀ1, 9b-[1,2,3]thiadiazoline
(15b).
N
(m, 10H, (CH2)5), 2.62 (s, 2H, CH2), 6.90–7.03 (m,
3H, ArH), 7.19–7.27 (m, 3H, ArH), 8.20 (d, J = 8.00
Hz, 2H, ArH), 10.38 ppm (br s, 1H, NH, exchange-
able with D2O). MS (EI): m/z (%) 351 (M, 100), 335
(24), 326 (11), 306 (15), 284 (13), 277 (17), 260 (11),
134 (15), 115 (25), 91 (9).
Yellow crystalline powder (2.20 g, 60%), mp 247–
248◦C. Anal calcd for C17H14ClN3O3S (375.81): C,
54.32; H, 3.75; N, 11.18; S, 8.53%. Found: C, 54.01;
H, 3.68; N, 10.98; S, 8.46%. IR (KBr): νC 1605
N
cm−1. H NMR (DMSO-d6): δ 1.43 (s, 6H, 2 CH3),
1
6.97–7.15 (m, 4H, ArH), 7.48–7.55 (m, 3H, ArH),